Lb Pharmaceuticals LBRX
NASDAQ LBRX
$40.81 -0.19 (-0.46%)
As of: Oct 21, 2026 · 10:20 AM EDT

Lb Pharmaceuticals (LBRX) EBIT (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) recorded EBIT of -$51.6 million in Q2 2026, compared with -$4.87 million a year earlier.

Analysis

Lb Pharmaceuticals (LBRX) EBIT (2024 - 2026) Analysis & Trends

On a TTM basis, Lb Pharmaceuticals' EBIT came in at -$85.68 million as of Jun 30, 2026; for FY2025, it came in at -$25.2 million.

  • Across earlier years, EBIT came in at -$63.1 million in FY2024.
  • The Q2 2026 figure is the lowest quarterly EBIT in data going back to Q3 2024.
  • Per Business Quant, the preceding three quarters came in at -$19.05 million (Q1 2026), -$11.47 million (Q4 2025) and -$3.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,132.91 Bn 1,101.50 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 615.07 Bn 533.59 Bn 17.26 Bn 7.14 Bn
3 AbbVie 505.92 Bn 479.03 Bn 12.70 Bn 6.43 Bn
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 298.25 Bn 262.24 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.76 Bn 235.45 Bn 12.86 Bn 3.16 Bn
7 Amgen 236.19 Bn 191.59 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn -10.39 Bn
9 Pfizer 170.37 Bn 117.02 Bn 10.94 Bn 4.27 Bn
10 Lb Pharmaceuticals 1.22 Bn -80.43 Mn - -51.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -51.60 Mn
Mar 31, 2026 -19.05 Mn
Dec 31, 2025 -11.47 Mn
Sep 30, 2025 -3.56 Mn
Jun 30, 2025 -4.87 Mn
Mar 31, 2025 -5.31 Mn
Dec 31, 2024 -5.07 Mn
Sep 30, 2024 -14.18 Mn
API Access

Lb Pharmaceuticals EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=LBRX&period=max&api_key=YOUR_API_KEY